AG˹ٷ

STOCK TITAN

[FWP] Morgan Stanley Free Writing Prospectus

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
FWP
Rhea-AI Filing Summary

Form 4 highlights: On 06/30/2025 Genworth Holdings, Inc., which remains the controlling stockholder of Enact Holdings, Inc. (ticker ACT), sold 691,152 Enact common shares to the issuer under an April 30, 2025 Share Repurchase Agreement. The transaction was coded “S� (sale) and priced at $35.4867 per share, a volume-weighted figure set by the agreement. Following the sale, Genworth still owns 120,243,555 shares, representing approximately 81 % of the outstanding stock, and reports the position as direct ownership.

The filing signals incremental execution of the parent-level liquidity strategy while modestly reducing Enact’s public float through an issuer buyback. No derivative securities were involved, and no change in board or executive relationships was disclosed.

Punti salienti del Modulo 4: Il 30/06/2025 Genworth Holdings, Inc., che rimane l'azionista di controllo di Enact Holdings, Inc. (simbolo ACT), ha venduto 691.152 azioni ordinarie Enact all'emittente nell'ambito di un Accordo di Riacquisto Azionario del 30 aprile 2025. La transazione è stata codificata come “S� (vendita) ed è stata effettuata al prezzo di $35,4867 per azione, un valore ponderato per volume stabilito dall'accordo. Dopo la vendita, Genworth detiene ancora 120.243.555 azioni, pari a circa il 81% delle azioni in circolazione, e segnala la posizione come proprietà diretta.

La comunicazione indica un'esecuzione incrementale della strategia di liquidità a livello di società madre, riducendo modestamente il flottante pubblico di Enact tramite un riacquisto da parte dell'emittente. Non sono stati coinvolti strumenti derivati e non sono stati comunicati cambiamenti nelle relazioni con il consiglio di amministrazione o i dirigenti.

Aspectos destacados del Formulario 4: El 30/06/2025, Genworth Holdings, Inc., que sigue siendo el accionista controlador de Enact Holdings, Inc. (símbolo ACT), vendió 691,152 acciones comunes de Enact al emisor bajo un Acuerdo de Recompra de Acciones del 30 de abril de 2025. La transacción fue codificada como “S� (venta) y se fijó a un precio de $35.4867 por acción, una cifra ponderada por volumen establecida por el acuerdo. Tras la venta, Genworth aún posee 120,243,555 acciones, que representan aproximadamente el 81 % de las acciones en circulación, y reporta esta posición como propiedad directa.

La presentación indica una ejecución incremental de la estrategia de liquidez a nivel matriz, reduciendo modestamente el flotante público de Enact mediante una recompra por parte del emisor. No se involucraron valores derivados y no se divulgaron cambios en las relaciones del consejo o ejecutivas.

Form 4 주요 내용: 2025� 6� 30�, Enact Holdings, Inc.(티커 ACT)� 지� 주주� Genworth Holdings, Inc.� 2025� 4� 30� 주식 재매� 계약� 따라 발행사에 691,152주의 Enact 보통주를 매도했습니다. 거래� “S�(매도)� 분류되었으며, 계약� 의해 정해� 거래� 가� 평균 가격인 주당 $35.4867� 이루어졌습니�. 매도 � Genworth� 여전� 120,243,555주를 보유하고 있으�, 이는 발행 주식� � 81%� 해당하며, 해당 지분을 직접 소유� 보고합니�.

� 신고� 모회� 차원� 유동� 전략� 점진적으� 실행되고 있음� 나타내며, 발행� 재매입을 통해 Enact� 공모 주식 수를 소폭 줄였습니�. 파생상품은 포함되지 않았으며, 이사회나 경영� 관계에 변화는 공개되지 않았습니�.

Points clés du Formulaire 4 : Le 30/06/2025, Genworth Holdings, Inc., qui reste l'actionnaire majoritaire d'Enact Holdings, Inc. (symbole ACT), a vendu 691 152 actions ordinaires Enact à l'émetteur dans le cadre d'un accord de rachat d'actions daté du 30 avril 2025. La transaction a été codée « S » (vente) et a été réalisée au prix pondéré par le volume fixé par l'accord, soit 35,4867 $ par action. Après la vente, Genworth détient toujours 120 243 555 actions, représentant environ 81 % des actions en circulation, et déclare cette position comme une propriété directe.

Ce dépôt indique une exécution progressive de la stratégie de liquidité au niveau de la société mère, tout en réduisant modestement le flottant public d'Enact via un rachat par l'émetteur. Aucun instrument dérivé n'a été impliqué, et aucun changement dans les relations du conseil d'administration ou de la direction n'a été divulgué.

Formular 4 Highlights: Am 30.06.2025 verkaufte Genworth Holdings, Inc., die weiterhin der Mehrheitsaktionär von Enact Holdings, Inc. (Ticker ACT) ist, 691.152 Enact-Stammaktien an den Emittenten im Rahmen einer Aktienrückkaufvereinbarung vom 30. April 2025. Die Transaktion wurde mit „S� (Verkauf) codiert und zu einem volumengewichteten Preis von 35,4867 $ pro Aktie, der durch die Vereinbarung festgelegt wurde, durchgeführt. Nach dem Verkauf hält Genworth weiterhin 120.243.555 Aktien, was etwa 81 % der ausstehenden Aktien entspricht, und meldet die Position als direkten Besitz.

Die Meldung signalisiert eine schrittweise Umsetzung der Liquiditätsstrategie auf Konzernebene, während der Streubesitz von Enact durch einen Rückkauf durch den Emittenten leicht reduziert wird. Es waren keine Derivate beteiligt, und es wurden keine Änderungen in den Beziehungen zu Vorstand oder Geschäftsführung bekannt gegeben.

Positive
  • Issuer-level share repurchase removes 691,152 shares from the public float without open-market pressure.
  • Rule 10b5-1 structured sale reduces insider-trading risk perception and adds transparency to Genworth’s divestiture plan.
Negative
  • Continued parent-level selling indicates Genworth may keep monetizing its stake, potentially leading to future share overhang.
  • Control concentration unchanged; minority shareholders still have limited influence with Genworth retaining ~81 % ownership.

Insights

TL;DR: Parent sold 0.6 % of stake back to Enact; float shrinks slightly, control unchanged, neutral-to-mildly positive for remaining shareholders.

The 691 k-share block represents roughly 0.4 % of Enact’s 173 m share base (implied from 81 % ownership figure), so the financial impact on EPS and book value is immaterial. However, buying directly from Genworth avoids open-market pressure and signals ongoing commitment to capital return after the April 2025 repurchase agreement. Genworth’s continued 81 % ownership means governance dynamics and dual-class risk are unchanged. From a liquidity standpoint, the parent’s gradual selldown may foreshadow future secondary offerings, but the small size and fixed pricing limit market read-through today.

TL;DR: Minor insider sale via structured agreement; control remains concentrated, governance profile unchanged.

The transaction was executed pursuant to a Rule 10b5-1-compliant repurchase contract, reducing concerns of opportunistic trading. Yet, it reinforces Genworth’s ability to monetize its stake outside public markets, limiting minority shareholders� influence. Because the ownership percentage did not move materially, board composition and related-party considerations stay the same. I view the event as low impact but a useful data point on the parent’s divestiture timeline.

Punti salienti del Modulo 4: Il 30/06/2025 Genworth Holdings, Inc., che rimane l'azionista di controllo di Enact Holdings, Inc. (simbolo ACT), ha venduto 691.152 azioni ordinarie Enact all'emittente nell'ambito di un Accordo di Riacquisto Azionario del 30 aprile 2025. La transazione è stata codificata come “S� (vendita) ed è stata effettuata al prezzo di $35,4867 per azione, un valore ponderato per volume stabilito dall'accordo. Dopo la vendita, Genworth detiene ancora 120.243.555 azioni, pari a circa il 81% delle azioni in circolazione, e segnala la posizione come proprietà diretta.

La comunicazione indica un'esecuzione incrementale della strategia di liquidità a livello di società madre, riducendo modestamente il flottante pubblico di Enact tramite un riacquisto da parte dell'emittente. Non sono stati coinvolti strumenti derivati e non sono stati comunicati cambiamenti nelle relazioni con il consiglio di amministrazione o i dirigenti.

Aspectos destacados del Formulario 4: El 30/06/2025, Genworth Holdings, Inc., que sigue siendo el accionista controlador de Enact Holdings, Inc. (símbolo ACT), vendió 691,152 acciones comunes de Enact al emisor bajo un Acuerdo de Recompra de Acciones del 30 de abril de 2025. La transacción fue codificada como “S� (venta) y se fijó a un precio de $35.4867 por acción, una cifra ponderada por volumen establecida por el acuerdo. Tras la venta, Genworth aún posee 120,243,555 acciones, que representan aproximadamente el 81 % de las acciones en circulación, y reporta esta posición como propiedad directa.

La presentación indica una ejecución incremental de la estrategia de liquidez a nivel matriz, reduciendo modestamente el flotante público de Enact mediante una recompra por parte del emisor. No se involucraron valores derivados y no se divulgaron cambios en las relaciones del consejo o ejecutivas.

Form 4 주요 내용: 2025� 6� 30�, Enact Holdings, Inc.(티커 ACT)� 지� 주주� Genworth Holdings, Inc.� 2025� 4� 30� 주식 재매� 계약� 따라 발행사에 691,152주의 Enact 보통주를 매도했습니다. 거래� “S�(매도)� 분류되었으며, 계약� 의해 정해� 거래� 가� 평균 가격인 주당 $35.4867� 이루어졌습니�. 매도 � Genworth� 여전� 120,243,555주를 보유하고 있으�, 이는 발행 주식� � 81%� 해당하며, 해당 지분을 직접 소유� 보고합니�.

� 신고� 모회� 차원� 유동� 전략� 점진적으� 실행되고 있음� 나타내며, 발행� 재매입을 통해 Enact� 공모 주식 수를 소폭 줄였습니�. 파생상품은 포함되지 않았으며, 이사회나 경영� 관계에 변화는 공개되지 않았습니�.

Points clés du Formulaire 4 : Le 30/06/2025, Genworth Holdings, Inc., qui reste l'actionnaire majoritaire d'Enact Holdings, Inc. (symbole ACT), a vendu 691 152 actions ordinaires Enact à l'émetteur dans le cadre d'un accord de rachat d'actions daté du 30 avril 2025. La transaction a été codée « S » (vente) et a été réalisée au prix pondéré par le volume fixé par l'accord, soit 35,4867 $ par action. Après la vente, Genworth détient toujours 120 243 555 actions, représentant environ 81 % des actions en circulation, et déclare cette position comme une propriété directe.

Ce dépôt indique une exécution progressive de la stratégie de liquidité au niveau de la société mère, tout en réduisant modestement le flottant public d'Enact via un rachat par l'émetteur. Aucun instrument dérivé n'a été impliqué, et aucun changement dans les relations du conseil d'administration ou de la direction n'a été divulgué.

Formular 4 Highlights: Am 30.06.2025 verkaufte Genworth Holdings, Inc., die weiterhin der Mehrheitsaktionär von Enact Holdings, Inc. (Ticker ACT) ist, 691.152 Enact-Stammaktien an den Emittenten im Rahmen einer Aktienrückkaufvereinbarung vom 30. April 2025. Die Transaktion wurde mit „S� (Verkauf) codiert und zu einem volumengewichteten Preis von 35,4867 $ pro Aktie, der durch die Vereinbarung festgelegt wurde, durchgeführt. Nach dem Verkauf hält Genworth weiterhin 120.243.555 Aktien, was etwa 81 % der ausstehenden Aktien entspricht, und meldet die Position als direkten Besitz.

Die Meldung signalisiert eine schrittweise Umsetzung der Liquiditätsstrategie auf Konzernebene, während der Streubesitz von Enact durch einen Rückkauf durch den Emittenten leicht reduziert wird. Es waren keine Derivate beteiligt, und es wurden keine Änderungen in den Beziehungen zu Vorstand oder Geschäftsführung bekannt gegeben.

Free Writing Prospectus to Preliminary Pricing Supplement No. 9,187

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 1, 2025; Filed pursuant to Rule 433

Morgan Stanley

SPXF40D4 Contingent Income Memory Auto-Callable Securities due August 1, 2030

This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.


Terms

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Underlier:

S&P® 500 Futures 40% Intraday 4% Decrement VT Index (SPXF40D4)

Automatic early redemption:

If, on any redemption determination date, the closing level of the underlier is greater than or equal to the call threshold level, the securities will be automatically redeemed. No further payments will be made on the securities once they have been automatically redeemed.

Call threshold level:

100% of the initial level

Redemption determination dates:

Beginning after 1 year, monthly

Contingent coupon:

12.00% to 13.00% per annum, with a memory feature. See the accompanying preliminary pricing supplement.

Coupon payment dates:

Monthly

Coupon barrier level:

75% of the initial level

Downside threshold level:

50% of the initial level

Pricing date:

July 28, 2025

Final observation date:

July 29, 2030

Maturity date:

August 1, 2030

CUSIP:

61778NGF2

Estimated value:

$894.90 per security, or within $44.90 of that estimate

Preliminary pricing supplement:

https://www.sec.gov/Archives/edgar/data/895421/000183988225036030/ms9187_424b2-19689.htm

1All payments are subject to our credit risk

 

Hypothetical Payment at Maturity1

(if the securities have not been automatically redeemed)

% Change in Closing Level of the Underlier

Payment at Maturity per Security (excluding any contingent coupon payable at maturity)

+100.00%

$1,000.00

+80.00%

$1,000.00

+60.00%

$1,000.00

+40.00%

$1,000.00

+20.00%

$1,000.00

0.00%

$1,000.00

-20.00%

$1,000.00

-40.00%

$1,000.00

-50.00%

$1,000.00

-51.00%

$490.00

-60.00%

$400.00

-80.00%

$200.00

-100.00%

$0.00



 

Free Writing Prospectus to Preliminary Pricing Supplement No. 9,187

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 1, 2025; Filed pursuant to Rule 433

Morgan Stanley

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

Underlier(s)

For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.

Risk Considerations

The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

Risks Relating to an Investment in the Securities

The securities do not guarantee the return of any principal.

The securities do not provide for the regular payment of interest.

Payment of the contingent coupon is based on the closing level of the underlier on only the related observation date at the end of the related interest period.

Investors will not participate in any appreciation in the value of the underlier.

The securities are subject to early redemption risk.

The market price of the securities may be influenced by many unpredictable factors.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

The securities will not be listed on any securities exchange and secondary trading may be limited.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain.

Risks Relating to the Underlier(s)

No assurance can be given that the investment strategy used to construct the underlier will achieve its intended results or that the underlier will be successful or will outperform any alternative index or strategy that might reference the futures contract.

The decrement of 4% per annum will adversely affect the performance of the underlier in all cases, whether the underlier appreciates or depreciates. The underlier includes a decrement feature, whereby 4% per annum is deducted daily from the level of the underlier.

The underlier is subject to risks associated with the use of significant leverage.

The underlier may not be fully invested.

The underlier was established on August 30, 2024 and therefore has very limited operating history.

As the underlier is new and has very limited historical performance, any investment in the underlier may involve greater risk than an investment in an index with longer actual historical performance and a proven track record.

Adjustments to the S&P® 500 Futures 40% Intraday 4% Decrement VT Index could adversely affect the value of the securities.

Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oHigher future prices of a futures contract to which the underlier is linked relative to its current prices may adversely affect the value of the underlier and the value of the securities.

oSuspensions or disruptions of market trading in futures markets could adversely affect the value of the securities.

oLegal and regulatory changes could adversely affect the return on and value of the securities.

Risks Relating to Conflicts of Interest

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities–United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.

 

FAQ

How many Enact (ACT) shares did Genworth sell on 06/30/2025?

691,152 common shares were sold to the issuer.

What price did the shares trade at under the repurchase agreement?

The weighted average price was $35.4867 per share, calculated per the agreement terms.

How many Enact shares does Genworth hold after the transaction?

Genworth now owns 120,243,555 shares, about 81 % of Enact’s outstanding stock.

Was the transaction open-market or a private agreement?

It was executed under a Share Repurchase Agreement dated 04/30/2025, not in the open market.

Did the filing involve any derivative securities?

No, Table II shows zero derivative activity in this Form 4.

Does this sale change Enact’s governance structure?

No, Genworth remains the controlling shareholder, so governance dynamics are unchanged.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

224.20B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
United States
NEW YORK